Doravirine (Pifeltro)

doravirine · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Doravirine (Pifeltro), covering 2019-02-15 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005) [Phase 1]

See pricing